
GSK vs INO
$GSK vs $INO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs INO: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Their trends point opposite ways: INO is above both its 50- and 200-day averages while GSK is below both.
- ·Neither kept up with the market over the past year: GSK +3.5% and INO -4.6%, against the S&P 500 at +8.8%.
- ·The last month has flipped the order: INO leads over the month (+113% against -4.1%) even though GSK leads over the year.
- ·INO has support 9.9% below at $1.60; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GSK vs INO: the quick read
- ·GSK is the larger company by market cap ($98.26B vs $317M).
- ·INO has been more active on our scanner (438 vs 73 alerts in 30 days).
- ·INO has the smaller float (186.1M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: INO is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·INO draws far more of our scanner's attention, 438 unusual-volume alerts in 30 days against 73, so it is the more actively traded of the two by some distance.
- ·They are not really peers by size: GSK is more than 310x the market cap of INO, so the same dollar of news moves INO far harder.
- ·GSK pays a dividend and INO does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: INO is outperforming the other by roughly 6.6 percentage points on the session.
Objective differences only. Not investment advice.
Watching GSK or INO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and INO on TheDesperateTrader.
- Is GSK or INO the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($98.26B vs $317M). INO has been more active on our scanner (438 vs 73 alerts in 30 days). INO has the smaller float (186.1M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and INO?
- The differences that matter: GSK is roughly 310x the size of the other by market cap ($98.26B vs $317M); they trade at very different share prices ($47.80 vs $1.77); GSK sits at 13% of its 52-week range against 56% for INO; only GSK pays a dividend; our scanner flagged GSK 73 times in the last 30 days against 438 for INO. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and INO is more active right now?
- Right now GSK is at about 0.5x its normal volume and INO is at about 0.6x, so INO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GSK or INO in the stronger trend?
- GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31; INO is above its 50-day average of $1.20 and above its 200-day average of $1.26. INO leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or INO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GSK and INO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.